Viewing Study NCT00258050


Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2025-12-25 @ 2:34 PM
Study NCT ID: NCT00258050
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module